CytomX Therapeutics Files 8-K
Ticker: CTMX · Form: 8-K · Filed: May 13, 2025 · CIK: 1501989
| Field | Detail |
|---|---|
| Company | Cytomx Therapeutics, INC. (CTMX) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financials
TL;DR
CytomX filed an 8-K on May 13th, reporting events from May 12th.
AI Summary
CytomX Therapeutics, Inc. filed an 8-K on May 13, 2025, reporting other events and financial statements. The filing date indicates the report was submitted on May 13, 2025, with the earliest event reported on May 12, 2025. The company is incorporated in Delaware and its principal executive offices are located in South San Francisco, California.
Why It Matters
This 8-K filing indicates a regulatory update from CytomX Therapeutics, Inc., which may contain important information regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any immediately alarming information.
Key Players & Entities
- CytomX Therapeutics, Inc. (company) — Registrant
- May 12, 2025 (date) — Earliest event reported
- May 13, 2025 (date) — Date of report
- South San Francisco, California (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by CytomX Therapeutics, Inc. in this 8-K filing?
The provided text does not detail the specific 'Other Events' reported, only that this item is included in the filing.
What is the significance of the 'Financial Statements and Exhibits' being listed as an item in this 8-K?
This indicates that the filing includes financial statements and/or exhibits, which could provide further details on the company's financial condition or other relevant information.
When was CytomX Therapeutics, Inc. incorporated, and in which jurisdiction?
CytomX Therapeutics, Inc. was incorporated in Delaware.
What is the business address and phone number for CytomX Therapeutics, Inc.?
The business address is 151 Oyster Point Blvd, Suite 400, South San Francisco, California, 94080, and the phone number is (650) 515-3185.
What is the SIC code for CytomX Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for CytomX Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding CytomX Therapeutics, Inc. (CTMX).